Skip to main content

The silent virus behind mono is now a prime suspect in major diseases

By Bloomberg  
   June 10, 2025

EBV was for years dismissed as a mild rite of passage — a virus that most people get and recover from, even though it stays in the body for life. But that view has been changing rapidly since a 2022 study provided strong evidence that EBV is a trigger for MS. Researchers also believe EBV plays a role in a wide range of serious conditions — from lupus and certain cancers to rheumatoid arthritis — and may trigger some cases of chronic fatigue syndrome. Some suspect it could be a hidden driver of long COVID.

Full story


Get the latest on healthcare leadership in your inbox.